Request that the FDA make a determination if the RLD, Inapsine Injection, 2.5mg/mL (N016796) was withdrawn for safety or effectiveness reasons | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2025-P-0253

Request that the FDA make a determination if the RLD, Inapsine Injection, 2.5mg/mL (N016796) was withdrawn for safety or effectiveness reasons

Documents

Comments

Description

CLOSED

Key Dates

Comment Period OpensJan 17, 2025

Documents

Type	Title	Posted	Comments	Status
Other	Response Letter from FDA CDER TO Regulatory Affairs Consulting	Apr 2, 2026	--

Keywords

CDER

Citizen Petition

Regulatory Affairs Consulting

make a determination if the RLD,

Inapsine Injection, 2.5mg/mL (N016796)

was withdrawn for safety or

effectiveness reasons

CLOSED

Data from Regulations.gov